OR WAIT null SECS
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Retinal specialists have reason to be excited this year, especially in the arena of developing treatments for age-related macular degeneration (AMD). In contrast to roughly 5 years ago, when only laser was available to arrest progression of extrafoveal vessels, now an array of approaches is on the horizon.